T3	Chemical 32 44	insulin-like
T4	Chemical 72 97	puromycin aminonucleoside
T6	Chemical 160 163	hGH
T8	Chemical 226 251	puromycin aminonucleoside
T10	Chemical 347 364	recombinant human
T11	Chemical 370 375	IGF-I
T13	Disease 420 434	growth failure
T15	Disease 456 471	PAN nephropathy
T16	Disease 477 491	glomerulopathy
T17	Chemical 588 595	rhIGF-I
T19	Chemical 666 673	rhIGF-I
T20	Disease 683 694	weight gain
T21	Disease 745 759	blood pressure
T22	Disease 773 786	renal disease
T25	Disease 870 885	PAN nephropathy
T26	Disease 1008 1019	body weight
T29	Disease 1170 1188	glomerulosclerosis
T30	Disease 1190 1215	tubulointerstitial injury
T31	Chemical 1235 1250	malondialdehyde
T32	Disease 1273 1288	PAN nephropathy
T33	Chemical 1308 1315	rhIGF-I
T34	Chemical 1326 1331	IGF-I
T35	Chemical 1336 1347	GH receptor
T36	Chemical 1408 1413	IGF-I
T38	Disease 1510 1521	weight gain
T39	Disease 1523 1537	blood pressure
T41	Chemical 1596 1611	malondialdehyde
T43	Chemical 1706 1713	rhIGF-I
T44	Chemical 1755 1765	IGF-I mRNA
T45	Chemical 1791 1806	gene expression
T46	Chemical 1814 1819	IGF-I
T47	Chemical 1823 1835	GH receptors
T48	Chemical 1876 1883	rhIGF-I
T49	Disease 1921 1944	chronic PAN nephropathy
T51	Chemical 1982 1989	rhIGF-I
T52	Disease 1999 2022	worsen renal functional
